Headquarters
22 ADELAIDE ST W STE 3400, TORONTO, ON M5H 4E3, CA
TORONTO, ON, CA
From the company
GoodCap Pharmaceuticals is a pharmaceutical company developing a multi-mechanism platform for neuroinflammation and brain health. Its lead candidate, GCAP001, is a dual-action neuroplastogen designed as a daily oral tablet to reduce inflammation and promote neural recovery. The company's first pivotal program targets PTSD, with a broader platform spanning depression, Parkinson's, and Alzheimer's.
22 ADELAIDE ST W STE 3400, TORONTO, ON M5H 4E3, CA
Quantities, certifications, and timing.